Andreas A. Weinberger
Aachen, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Six-Month Real-World Data in Macular Edema Due to Retinal Vein Occlusion Treated with Faricimab: Swiss Retina Research Network Report.
Journal: Ophthalmology and therapy
Published: May 04, 2026
Correction: One-Year Outcomes of Faricimab in Treatment-Naïve Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network Report.
Journal: Ophthalmology and therapy
Published: February 28, 2026
Starry Nights and Fading Vision: PAMM Through the Eyes of a Patient.
Journal: Klinische Monatsblatter fur Augenheilkunde
Published: February 23, 2026
One-Year Real-World Outcomes of Switching to Aflibercept 8 mg in Eyes with Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network Report.
Journal: Ophthalmology and therapy
Published: January 06, 2026
Prevalence of Polypoidal Choroidal Vasculopathy Beyond Recalcitrant Macular Neovasculopathies in a European AMD Cohort and Therapeutic Response to Brolucizumab.
Journal: Journal of clinical medicine
Published: December 31, 2025
Twelve-Month Outcomes Using Aflibercept 8 mg in Treatment-Naïve and Pretreated Diabetic Macular Edema: A Swiss Retina Research Network Report.
Journal: Ophthalmology science
Published: November 08, 2025
First-year real-world outcomes of faricimab in clinically significant diabetic macular oedema: a Swiss retina research network report.
Journal: BMJ open ophthalmology
Published: September 01, 2025
One-Year Outcomes of Faricimab in Treatment-Naïve Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network Report.
Journal: Ophthalmology and therapy
Published: August 11, 2025
Long-term Follow-up of an Atypical Macular Hole Treated with 25 G Pars Plana Vitrectomy (ppV), ILM Peeling and 16% C2F6 Gas Tamponade.
Journal: Klinische Monatsblatter fur Augenheilkunde
Published: April 16, 2025
One-Year Outcomes after Switching to Faricimab in Eyes with Pretreated Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network Report.
Journal: Ophthalmology. Retina
Published: December 01, 2024
Chorioretinal Toxicity of Perfluorooctane (Ala Octa): Results From 48 Surgical Procedures in Geneva.
Chorioretinal Toxicity of Perfluorooctane (Ala Octa): Results From 48 Surgical Procedures in Geneva.
Journal: American journal of ophthalmology
Published: July 22, 2019
Lipemia retinalis: contribution of ultra-widefield imaging and spectral domain OCT
Journal: Journal francais d'ophtalmologie
Published: March 19, 2019
Last Updated: 09/26/2026